These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31888533)

  • 1. Estimating the risk of acute kidney injury associated with use of diuretics and renin angiotensin aldosterone system inhibitors: A population based cohort study using the clinical practice research datalink.
    Scott J; Jones T; Redaniel MT; May MT; Ben-Shlomo Y; Caskey F
    BMC Nephrol; 2019 Dec; 20(1):481. PubMed ID: 31888533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study.
    Mansfield KE; Nitsch D; Smeeth L; Bhaskaran K; Tomlinson LA
    BMJ Open; 2016 Dec; 6(12):e012690. PubMed ID: 28003286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury.
    Dreischulte T; Morales DR; Bell S; Guthrie B
    Kidney Int; 2015 Aug; 88(2):396-403. PubMed ID: 25874600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the combination of diuretics, renin-angiotensin-aldosterone system inhibitors, and non-steroidal anti-inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case-control study.
    Calvo DM; Saiz LC; Leache L; Celaya MC; Gutiérrez-Valencia M; Alonso A; Erviti J; Alzueta N; Echeverría A; Garjón J; Fontela C; Sanz L; Acín MT; Fernández ML; Gómez N
    Pharmacoepidemiol Drug Saf; 2023 Aug; 32(8):898-909. PubMed ID: 36960493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-steroidal anti-inflammatory drugs, renin-angiotensin system blockade or diuretics and risk of acute kidney injury: A case-crossover study.
    Weng SE; Hsu WT; Hsiao FY; Lee CM
    Arch Gerontol Geriatr; 2024 Aug; 123():105394. PubMed ID: 38537386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Acute Kidney Disease after an Episode of AKI: A Multicenter Prospective Cohort Study.
    Hines A; Li X; Ortiz-Soriano V; Saleh S; Litteral J; Ruiz-Conejo M; Wald R; Silver SA; Neyra JA
    Am J Nephrol; 2020; 51(4):266-275. PubMed ID: 32088714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of acute kidney injury by initiation of non-steroidal anti-inflammatory drugs in hospitalised patients treated with diuretics and renin-angiotensin-aldosterone system inhibitors.
    Bories M; Bacle A; Gilardi H; Le Corre P
    Eur J Hosp Pharm; 2022 Nov; 29(6):359-361. PubMed ID: 33478983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre- and/or Intra-Operative Prescription of Diuretics, but Not Renin-Angiotensin-System Inhibitors, Is Significantly Associated with Acute Kidney Injury after Non-Cardiac Surgery: A Retrospective Cohort Study.
    Tagawa M; Ogata A; Hamano T
    PLoS One; 2015; 10(7):e0132507. PubMed ID: 26146836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care.
    Bidulka P; Fu EL; Leyrat C; Kalogirou F; McAllister KSL; Kingdon EJ; Mansfield KE; Iwagami M; Smeeth L; Clase CM; Bhaskaran K; van Diepen M; Carrero JJ; Nitsch D; Tomlinson LA
    BMC Med; 2020 Jul; 18(1):195. PubMed ID: 32723383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
    Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
    Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.
    Hsu CY; Liu KD; Yang J; Glidden DV; Tan TC; Pravoverov L; Zheng S; Go AS
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):26-34. PubMed ID: 31843974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.
    de Abajo FJ; Rodríguez-Martín S; Lerma V; Mejía-Abril G; Aguilar M; García-Luque A; Laredo L; Laosa O; Centeno-Soto GA; Ángeles Gálvez M; Puerro M; González-Rojano E; Pedraza L; de Pablo I; Abad-Santos F; Rodríguez-Mañas L; Gil M; Tobías A; Rodríguez-Miguel A; Rodríguez-Puyol D;
    Lancet; 2020 May; 395(10238):1705-1714. PubMed ID: 32416785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risks and benefits of patients temporarily discontinuing medications in the event of an intercurrent illness: a systematic review protocol.
    Morden A; Horwood J; Whiting P; Savovic J; Tomlinson L; Blakeman T; Tomson C; Richards A; Stone T; Caskey F
    Syst Rev; 2015 Oct; 4():139. PubMed ID: 26497494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system blocker use and the risk of acute kidney injury after colorectal cancer surgery: a population-based cohort study.
    Slagelse C; Gammelager H; Iversen LH; Liu KD; Sørensen HT; Christiansen CF
    BMJ Open; 2019 Nov; 9(11):e032964. PubMed ID: 31753901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-Converting Enzyme Inhibitor/Receptor Blocker, Diuretic, or Nonsteroidal Anti-inflammatory Drug Use After Major Surgery and Acute Kidney Injury: A Case-Control Study.
    Roberts DJ; Smith SA; Tan Z; Dixon E; Datta I; Devrome A; Hemmelgarn BR; Tonelli M; Pannu N; James MT
    J Surg Res; 2021 Jul; 263():34-43. PubMed ID: 33631376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of vasopressin receptor antagonists on triple-whammy acute kidney injury: A VigiBase analysis.
    Mitsuboshi S; Hayakawa K; Hamano H; Oshima A; Takeda T; Murakawa K; Mori H; Zamami Y
    Br J Clin Pharmacol; 2024 Mar; 90(3):900-904. PubMed ID: 37990649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study.
    Kitchlu A; McArthur E; Amir E; Booth CM; Sutradhar R; Majeed H; Nash DM; Silver SA; Garg AX; Chan CT; Kim SJ; Wald R
    J Natl Cancer Inst; 2019 Jul; 111(7):727-736. PubMed ID: 30423160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: "The Triple Whammy".
    Camin RM; Cols M; Chevarria JL; Osuna RG; Carreras M; Lisbona JM; Coderch J
    Nefrologia; 2015; 35(2):197-206. PubMed ID: 26300514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal safety and survival among acutely ill hospitalized patients treated by blockers of the Renin-Angiotensin axis or loop diuretics: a single-center retrospective analysis.
    Assaly M; Gorelik Y; Heyman SN; Abassi Z; Khamaisi M
    Ren Fail; 2023; 45(2):2282707. PubMed ID: 37975172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality After Sepsis: A Population-Based Cohort Study.
    Hsu WT; Galm BP; Schrank G; Hsu TC; Lee SH; Park JY; Lee CC
    Hypertension; 2020 Feb; 75(2):483-491. PubMed ID: 31838905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.